Over the decades, many strains of disease-causing bacteria have evolved defenses to even the most potent antibiotics, setting ...

Researchers report how Paenibacillus avoids harm by its own antibiotic — information that is crucial for developing new drug ...

The funding will support final development, clinical validation, regulatory approval, and commercial launch of an ultra-rapid AST platform.

Shanx Medtech BV raised €15 million (US$17.5 million) in a seed funding round for its in vitro diagnostic platform for ultra-rapid antimicrobial susceptibility testing. The financing came from a range ...

ABSTRACT: Staphylococcus aureus is an important foodborne pathogen that is of major concern to public health especially when it becomes resistant to a last-line drug of choice like vancomycin. As the ...

A new rapid test could improve treatment of urinary tract infections, by identifying the most effective antibiotic for each individual patient. The test applies different antibiotics to bacteria found ...